Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.
about
Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan.Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitmentSeroprevalence of human papillomavirus immunoglobulin G antibodies among women presenting at the reproductive health clinic of a university teaching hospital in Nigeria.Prevalence of HPV infection and other risk factors in a Fijian population.Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: the Hawaii HPV Cohort Study.Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study.Incident cervical infections with high- and low-risk human papillomavirus (HPV) infections among mothers in the prospective Finnish Family HPV Study.Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV studySynergistic effect of viral load and alcohol consumption on the risk of persistent high-risk human papillomavirus infection.Meta-analysis of human papillomavirus infection concordance.HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study.Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study.Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial.The influence of multiple human papillomavirus types on the risk of genotype-concordant incident infections of the anus and cervix: the Hawaii HPV cohort study.A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica.The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model.Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection.Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age.Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling.A prospective study of age trends of high-risk human papillomavirus infection in rural China.Cervical and anal human papillomavirus infection in adult women in American Samoa.Facebook for Health Promotion: Female College Students' Perspectives on Sharing HPV Vaccine Information Through Facebook.Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response?Burden of Human Papillomavirus among Haitian Immigrants in Miami, Florida: Community-Based Participatory Research in Action.Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature.Prevalence and seroprevalence of low-risk human papillomavirus in Korean women.Population-based study on the prevalence of and risk factors for human papillomavirus infection in Qujing of Yunnan province, Southwest ChinaContributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older womenHPV prevalence at enrollment and baseline results from the Carolina Women's Care Study, a longitudinal study of HPV persistence in women of college age.Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort studyDuration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study.Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus.Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer.Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?Prevalence of anal cytological abnormalities in women with positive cervical cytology.Epidemiology of Humanpapilloma virus infection among women in Fujian, China.Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.
P2860
Q33523171-1131E5E8-E3C2-4752-82C9-12C0F031EC7EQ33596805-DAB97AFD-E7E1-448B-8650-E15381292645Q33641116-9542E6DD-5188-45B1-9513-6FAD68CA2A72Q33694151-7B0CFE1B-6A73-4893-98EB-CFEBC6E23518Q33698774-A171B5BA-CBF3-411C-A3D7-52F0293EA833Q33776519-13629A4D-2EDD-4911-AD7E-1D9F62C3334EQ33803206-B400154B-5758-4DB0-AC71-518657942DDEQ33940157-5D575DB7-FB17-48CA-8B86-BAB197E9875DQ34046478-21503945-89AF-4E78-8248-F131F749E346Q34070551-7A05825D-6C1F-4D50-B60B-8BABE588EEAEQ34293114-F6182D35-1FF6-49B0-8A22-353FFBB31DE6Q34448633-B1F40EC6-7211-4061-9623-D0E0E7CDA4F1Q34542473-19AB9A97-D1E9-4F02-980C-A6BA39D757D5Q34739688-FF93E7FC-0F7B-4F50-BB6B-B55FB2CBDD07Q34763938-81EEBF71-04A5-45D4-BEF1-ABC7D0B0EB78Q34802732-53460242-6A0B-42FE-A681-FF9577245AFEQ35038766-75CA61CE-1527-497B-8977-007E1C3DAA95Q35039759-D68ECF37-2D4A-4F5B-988E-4F09F1C988D4Q35078593-A7B031CE-A1AD-4138-B93D-5AF2359FA1B8Q35094044-A685B22F-8867-4EC7-A6C2-8E247F57C33DQ35100159-BBF2DB1D-B6E5-48C4-8FC2-45972A59DCA9Q35433626-38D4A8A7-5913-4D38-A52A-1A29EEFE822FQ35530787-832D5996-CC5F-40BC-B54B-B88A5C7680A3Q35870615-AB5A726E-49D4-42B3-AFBD-EEC17909508DQ35949799-1E7D9F33-141F-44CE-AEB5-84B8FB85AFCDQ35974650-414974EB-D1AF-49A2-9055-8C900C3E2958Q36052323-D1EE01CE-BC1D-4DFB-8659-999CE0C82E79Q36134618-1B99A6D7-3BF8-4CC7-A5F0-0A5BCAE0484DQ36427407-6731BAD4-3E33-44F8-832E-4C13F8FBA053Q36442227-2DEADDBE-D255-48A7-8EB7-65CE785FF017Q36992158-E7083ABF-0D1B-4B7A-B1CC-1115C7D34C43Q37001336-6FA76DFA-FCA2-4AB8-86C3-BCD76C656E6EQ37067273-DE159562-BFDF-4666-829C-E6C1D629D163Q37373076-79250E51-AFE8-40E1-8B51-A4904FA69E70Q37691615-1E58CF08-E3F2-48A9-BE1D-256FD5788CABQ37700184-370C2571-1921-4EA0-98F8-81D15C6E9FFEQ37943790-EADDAD30-6C44-469A-8E6C-03A6C8278BF9Q39761161-886B5A69-088E-4DC9-9060-2705D99988CDQ40095873-5AF52B9C-A1C9-45F2-951E-D70EF40874FAQ40348516-274C2B5B-04E1-4AB2-8D22-60395590D732
P2860
Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Prevalence, acquisition, and c ...... n Papillomavirus Cohort Study.
@en
Prevalence, acquisition, and c ...... n Papillomavirus Cohort Study.
@nl
type
label
Prevalence, acquisition, and c ...... n Papillomavirus Cohort Study.
@en
Prevalence, acquisition, and c ...... n Papillomavirus Cohort Study.
@nl
prefLabel
Prevalence, acquisition, and c ...... n Papillomavirus Cohort Study.
@en
Prevalence, acquisition, and c ...... n Papillomavirus Cohort Study.
@nl
P2093
P2860
P1433
P1476
Prevalence, acquisition, and c ...... n Papillomavirus Cohort Study.
@en
P2093
Brenda Y Hernandez
Jeffrey Killeen
Katharine McDuffie
Lori Kamemoto
Lynne R Wilkens
Marc T Goodman
Pamela J Thompson
Xuemei Zhu
Yurii B Shvetsov
P2860
P304
P356
10.1158/0008-5472.CAN-08-1380
P407
P577
2008-11-01T00:00:00Z